# US 6,730,491 B2 · 2504, 15977, and 14760, novel protein kinase family members and uses therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,491 B2
- Document ID: US6730491B2
- Status: Granted
- Kind: B2
- Application number: 09/797,039
- Filed: 2001-02-28
- Published: 2002-04-11
- Granted: 2004-05-04
- Earliest claimed: 2000-02-29
- Assignees: Millennium Pharmaceuticals, Inc.
- Inventors: Rosana Kapeller-Libermann; Rachel A. Meyers; Rory A. J. Curtis
- Web page: https://patentgrep.com/patent/US6730491B2

## CPC

- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C07K 16/40: against enzymes
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2039/505: {comprising antibodies}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention provides isolated nucleic acids molecules, designated 2504, 15977, or 14760 nucleic acid molecules, which encode novel protein kinase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 2504, 15977, or 14760 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 2504, 15977, or 14760 gene has been introduced or disrupted. The invention still further provides isolated 2504, 15977, or 14760 proteins, fusion proteins, antigenic peptides and anti-2504, 15977, or 14760 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

## Claims

### Claim 1

A method for identifying a compound which binds to a polypeptide comprising the amino acid sequence of SEQ ID NO:5, comprising the steps of:
a) contacting the polypeptide, or a cell expressing the polypeptide with a test compound under conditions suitable for binding; and
b) determining whether the polypeptide binds to the test compound.

### Claim 2 (depends on 1)

The method of claim 1, wherein the binding of the test compound to the polypeptide is detected by a method selected from the group consisting of:
a) direct detecting of test compound/polypeptide binding;
b) a competition binding assay;
c) an immunoassay;
d) a yeast two-hybrid assay; and
e) a protein kinase assay.

### Claim 3

A method for identifying a compound which modulates the activity of a polypeptide comprising the amino acid sequence of SEQ ID NO:5, comprising:
a) contacting the polypeptide, or a cell expressing the polypeptide with a test compound under conditions suitable for binding; and
b) determining the effect of the test compound on the activity of the polypeptide to thereby identify a compound which modulates the activity of the polypeptide.

### Claim 4

A method for identifying an agent which modulates the activity or expression of a polypeptide comprising the amino acid sequence of SEQ ID NO:5 or a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:5, comprising contacting the polypeptide or the nucleic acid with a test agent; and determining the effect of the test agent on the activity or expression of the polypeptide or nucleic acid.

### Claim 5 (depends on 4)

The method of claim 4, wherein the activity is proliferation, differentiation, or survival of a cell expressing a polypeptide comprising the amino acid sequence of SEQ ID NO:5 or a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:5.

### Claim 6 (depends on 5)

The method of claim 5, wherein the cell is selected from the group consisting of an epithelial cell, a cardiovascular cell, a hematopoietic cell, a skeletal muscle cell, and a neural cell.
